Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Femoral Nerve Blockade 7.5 ml of 1% Lidocaine: US Guidance Versus US Guidance With Electrical Stimulation of Peripheral Nerves

NCT05209711 is registered in ClinicalTrials.gov with Mogilev Regional Clinical Hospital as lead sponsor.

NCT NCT05209711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05209711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Femoral Nerve Blockade 7.5 ml of 1% Lidocaine: US Guidance Versus US Guidance With Electrical Stimulation of Peripheral Nerves
Lead sponsor
Mogilev Regional Clinical Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2022
Completion date
October 31, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

efficiency, femoral nerve, minimum effective dose, nerve block, ultrasonography